United States Pharmaceuticals

Aptinyx Inc (APTX)

Track

Track

Ticker: APTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Miller Joan W. Non-Executive Director
Transaction date
Purchase
Price
453.20
Quantity 9,306 -42.6%
Value US$4,716,131
3.4
RIEDEL NORBERT G CEO Executive Director
Transaction date
Purchase
Price
455.19
Quantity 43,580 +5.7%
Value US$2,202,447
KHANNA ASHISH CFO AND CBO Officer
Transaction date
Purchase
Price
319.42
Quantity 53,537 +34.1%
Value US$2,805,324
HOMBACH ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
2.40
Quantity 74,600 +51.6%
Value US$179,040
HOMBACH ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
2.40
Quantity 5,400 +3.9%
Value US$12,960
Sherman Rachel E.
Transaction date
Purchase
Price
4.79
Quantity 2,174 +inf%
Value US$10,413
4.0
Koppel Adam Large shareholder
Transaction date
Purchase
Price
3.00
Quantity 3,333,333 +149.8%
Value US$9,999,999
3.6
ENRIGHT PATRICK G
Transaction date
Purchase
Price
3.00
Quantity 166,667 +5.2%
Value US$500,001
3.6
ENRIGHT PATRICK G
Transaction date
Purchase
Price
3.00
Quantity 95,000 +inf%
Value US$285,000
HOMBACH ROBERT J.
Transaction date
Purchase
Price
3.00
Quantity 50,000 +56.1%
Value US$150,000
3.2
Gosebruch Henry O
Transaction date
Purchase
Price
3.00
Quantity 25,000 +25.0%
Value US$75,000
3.4
RIEDEL NORBERT G CEO and President Executive Director
Transaction date
Purchase
Price
3.00
Quantity 35,000 +inf%
Value US$105,000
HOMBACH ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
3.24
Quantity 50,000 +127.9%
Value US$161,750
3.2
Gosebruch Henry O
Transaction date
Purchase
Price
3.86
Quantity 96,580 +2824.0%
Value US$372,799
3.2
Gosebruch Henry O
Transaction date
Purchase
Price
3.75
Quantity 3,420 +inf%
Value US$12,825
Madsen Torsten M. Chief Medical Officer Officer
Transaction date
Purchase
Price
5.27
Quantity 1,050 +0.5%
Value US$5,534
HOMBACH ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
5.54
Quantity 11,655 +31.1%
Value US$64,569
HOMBACH ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
5.52
Quantity 13,345 +55.4%
Value US$73,664
KHANNA ASHISH CFO and CBO Officer
Transaction date
Purchase
Price
5.45
Quantity 10,000 +3.7%
Value US$54,500
Frazier Life Sciences VIII, L.P. Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 150,000 +4.9%
Value US$2,400,000
New Leaf Venture Management III, L.L.C. Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 125,000 +51.4%
Value US$2,000,000
New Leaf Venture Management III, L.L.C. Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 125,000 +4.5%
Value US$2,000,000
MOSKAL JOSEPH R. Chief Scientific Officer Officer
Transaction date
Purchase
Price
16.00
Quantity 3,000 +0.8%
Value US$48,000
Koppel Adam Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 400,000 +21.9%
Value US$6,400,000
Gould Terry P Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 52,471 +4.9%
Value US$839,536
Gould Terry P Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 15,741 +4.9%
Value US$251,856
Gould Terry P Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 18,068 +4.9%
Value US$289,088
Gould Terry P Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 23,538 +4.4%
Value US$376,608
Gould Terry P Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 17,305 +4.4%
Value US$276,880
Gould Terry P Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 22,877 +4.4%
Value US$366,032
Longitude Capital Partners II, LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 150,000 +4.9%
Value US$2,400,000
HOMBACH ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
16.00
Quantity 24,100 +inf%
Value US$385,600
KIDD ANDREW Chief Commercial Officer Officer
Transaction date
Purchase
Price
16.00
Quantity 6,700 +275.4%
Value US$107,200
Topper James N Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 150,000 +4.9%
Value US$2,400,000
Madsen Torsten M. Chief Medical Officer Officer
Transaction date
Purchase
Price
16.00
Quantity 1,000 +0.4%
Value US$16,000
Ratcliffe Liam Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 125,000 +51.4%
Value US$2,000,000
Ratcliffe Liam Non-Executive Director Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 125,000 +4.5%
Value US$2,000,000
KHANNA ASHISH CFO and CBO Officer
Transaction date
Purchase
Price
16.00
Quantity 1,800 +inf%
Value US$28,800
KHANNA ASHISH CFO and CBO Officer
Transaction date
Purchase
Price
16.00
Quantity 6,000 +2.2%
Value US$96,000
RIEDEL NORBERT G CEO and President Executive Director
Transaction date
Purchase
Price
16.00
Quantity 2,400 +88.3%
Value US$38,400
ENRIGHT PATRICK G
Transaction date
Purchase
Price
16.00
Quantity 150,000 +4.9%
Value US$2,400,000
GANTZ WILBUR H
Transaction date
Purchase
Price
16.00
Quantity 6,100 +8.2%
Value US$97,600
GANTZ WILBUR H
Transaction date
Purchase
Price
16.00
Quantity 17,000 +4.8%
Value US$272,000
ADAMS STREET PARTNERS LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 52,471 +4.9%
Value US$839,536
ADAMS STREET PARTNERS LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 15,741 +4.9%
Value US$251,856
ADAMS STREET PARTNERS LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 18,068 +4.9%
Value US$289,088
ADAMS STREET PARTNERS LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 23,538 +4.4%
Value US$376,608
ADAMS STREET PARTNERS LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 17,305 +4.4%
Value US$276,880
ADAMS STREET PARTNERS LLC Large shareholder
Transaction date
Purchase
Price
16.00
Quantity 22,877 +4.4%
Value US$366,032
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-01-18 2022-01-13 B Purchase
Miller Joan W.
Non-Executive Director
9,306 -42.6%
453.20
US$4,716,131 		9,306 -42.6% 453.20 US$4,716,131
2021-12-08 2021-12-06 B Purchase
3.4
RIEDEL NORBERT G

CEO

Executive Director
43,580 +5.7%
455.19
US$2,202,447 		43,580 +5.7% 455.19 US$2,202,447
2021-12-06 2021-12-02 B Purchase
KHANNA ASHISH

CFO AND CBO

Officer
53,537 +34.1%
319.42
US$2,805,324 		53,537 +34.1% 319.42 US$2,805,324
2021-11-15 2021-11-12 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
74,600 +51.6%
2.40
US$179,040 		74,600 +51.6% 2.40 US$179,040
2021-11-15 2021-11-11 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
5,400 +3.9%
2.40
US$12,960 		5,400 +3.9% 2.40 US$12,960
2020-10-27 2020-10-26 B Purchase
2.8
Bain Capital Life Sciences Investors, LLC
Large shareholder
3,333,333 +60.0%
3.00
US$9,999,999 		3,333,333 +60.0% 3.00 US$9,999,999
2020-01-23 2020-01-22 B Purchase
Sherman Rachel E.
2,174 +inf%
4.79
US$10,413 		2,174 +inf% 4.79 US$10,413
2020-01-16 2020-01-14 B Purchase
4.0
Koppel Adam
Large shareholder
3,333,333 +149.8%
3.00
US$9,999,999 		3,333,333 +149.8% 3.00 US$9,999,999
2020-01-14 2020-01-10 B Purchase
3.6
ENRIGHT PATRICK G
166,667 +5.2%
3.00
US$500,001 		166,667 +5.2% 3.00 US$500,001
2020-01-14 2020-01-10 B Purchase
3.6
ENRIGHT PATRICK G
95,000 +inf%
3.00
US$285,000 		95,000 +inf% 3.00 US$285,000
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
349,806 +31.3%
3.00
US$1,049,418 		349,806 +31.3% 3.00 US$1,049,418
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
104,942 +31.3%
3.00
US$314,826 		104,942 +31.3% 3.00 US$314,826
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
120,453 +31.3%
3.00
US$361,359 		120,453 +31.3% 3.00 US$361,359
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
156,920 +28.3%
3.00
US$470,760 		156,920 +28.3% 3.00 US$470,760
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
115,367 +28.3%
3.00
US$346,101 		115,367 +28.3% 3.00 US$346,101
2020-01-14 2020-01-10 B Purchase
2.6
ADAMS STREET PARTNERS LLC
Large shareholder
152,512 +28.3%
3.00
US$457,536 		152,512 +28.3% 3.00 US$457,536
2020-01-14 2020-01-10 B Purchase
HOMBACH ROBERT J.
50,000 +56.1%
3.00
US$150,000 		50,000 +56.1% 3.00 US$150,000
2020-01-14 2020-01-10 B Purchase
3.2
Gosebruch Henry O
25,000 +25.0%
3.00
US$75,000 		25,000 +25.0% 3.00 US$75,000
2020-01-14 2020-01-10 B Purchase
3.4
RIEDEL NORBERT G

CEO and President

Executive Director
35,000 +inf%
3.00
US$105,000 		35,000 +inf% 3.00 US$105,000
2019-11-26 2019-11-22 B Purchase HOMBACH ROBERT J. Non-Executive Director
50,000 +127.9%
3.24
US$161,750 		50,000 +127.9% 3.24 US$161,750
2019-05-09 2019-05-08 B Purchase
3.2
Gosebruch Henry O
96,580 +2824.0%
3.86
US$372,799 		96,580 +2824.0% 3.86 US$372,799
2019-05-09 2019-05-07 B Purchase
3.2
Gosebruch Henry O
3,420 +inf%
3.75
US$12,825 		3,420 +inf% 3.75 US$12,825
2019-01-30 2019-01-28 B Purchase
Madsen Torsten M.

Chief Medical Officer

Officer
1,050 +0.5%
5.27
US$5,534 		1,050 +0.5% 5.27 US$5,534
2019-01-28 2019-01-25 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
11,655 +31.1%
5.54
US$64,569 		11,655 +31.1% 5.54 US$64,569
2019-01-28 2019-01-24 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
13,345 +55.4%
5.52
US$73,664 		13,345 +55.4% 5.52 US$73,664
2019-01-18 2019-01-18 B Purchase
KHANNA ASHISH

CFO and CBO

Officer
10,000 +3.7%
5.45
US$54,500 		10,000 +3.7% 5.45 US$54,500
2018-06-26 2018-06-25 B Purchase Frazier Life Sciences VIII, L.P. Large shareholder
150,000 +4.9%
16.00
US$2,400,000 		150,000 +4.9% 16.00 US$2,400,000
2018-06-26 2018-06-25 B Purchase New Leaf Venture Management III, L.L.C. Large shareholder
125,000 +51.4%
16.00
US$2,000,000 		125,000 +51.4% 16.00 US$2,000,000
2018-06-26 2018-06-25 B Purchase New Leaf Venture Management III, L.L.C. Large shareholder
125,000 +4.5%
16.00
US$2,000,000 		125,000 +4.5% 16.00 US$2,000,000
2018-06-26 2018-06-25 B Purchase MOSKAL JOSEPH R.

Chief Scientific Officer

Officer
3,000 +0.8%
16.00
US$48,000 		3,000 +0.8% 16.00 US$48,000
2018-06-26 2018-06-25 B Purchase Koppel Adam Non-Executive Director
400,000 +21.9%
16.00
US$6,400,000 		400,000 +21.9% 16.00 US$6,400,000
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
52,471 +4.9%
16.00
US$839,536 		52,471 +4.9% 16.00 US$839,536
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
15,741 +4.9%
16.00
US$251,856 		15,741 +4.9% 16.00 US$251,856
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
18,068 +4.9%
16.00
US$289,088 		18,068 +4.9% 16.00 US$289,088
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
23,538 +4.4%
16.00
US$376,608 		23,538 +4.4% 16.00 US$376,608
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
17,305 +4.4%
16.00
US$276,880 		17,305 +4.4% 16.00 US$276,880
2018-06-26 2018-06-25 B Purchase Gould Terry P Non-Executive Director Large shareholder
22,877 +4.4%
16.00
US$366,032 		22,877 +4.4% 16.00 US$366,032
2018-06-26 2018-06-25 B Purchase Longitude Capital Partners II, LLC Large shareholder
150,000 +4.9%
16.00
US$2,400,000 		150,000 +4.9% 16.00 US$2,400,000
2018-06-26 2018-06-25 B Purchase HOMBACH ROBERT J. Non-Executive Director
24,100 +inf%
16.00
US$385,600 		24,100 +inf% 16.00 US$385,600
2018-06-26 2018-06-25 B Purchase KIDD ANDREW

Chief Commercial Officer

Officer
6,700 +275.4%
16.00
US$107,200 		6,700 +275.4% 16.00 US$107,200
2018-06-26 2018-06-25 B Purchase Topper James N Non-Executive Director Large shareholder
150,000 +4.9%
16.00
US$2,400,000 		150,000 +4.9% 16.00 US$2,400,000
2018-06-26 2018-06-25 B Purchase Madsen Torsten M.

Chief Medical Officer

Officer
1,000 +0.4%
16.00
US$16,000 		1,000 +0.4% 16.00 US$16,000
2018-06-26 2018-06-25 B Purchase Ratcliffe Liam Non-Executive Director Large shareholder
125,000 +51.4%
16.00
US$2,000,000 		125,000 +51.4% 16.00 US$2,000,000
2018-06-26 2018-06-25 B Purchase Ratcliffe Liam Non-Executive Director Large shareholder
125,000 +4.5%
16.00
US$2,000,000 		125,000 +4.5% 16.00 US$2,000,000
2018-06-26 2018-06-25 B Purchase KHANNA ASHISH

CFO and CBO

Officer
1,800 +inf%
16.00
US$28,800 		1,800 +inf% 16.00 US$28,800
2018-06-26 2018-06-25 B Purchase KHANNA ASHISH

CFO and CBO

Officer
6,000 +2.2%
16.00
US$96,000 		6,000 +2.2% 16.00 US$96,000
2018-06-26 2018-06-25 B Purchase RIEDEL NORBERT G

CEO and President

Executive Director
2,400 +88.3%
16.00
US$38,400 		2,400 +88.3% 16.00 US$38,400
2018-06-26 2018-06-25 B Purchase ENRIGHT PATRICK G
150,000 +4.9%
16.00
US$2,400,000 		150,000 +4.9% 16.00 US$2,400,000
2018-06-26 2018-06-25 B Purchase GANTZ WILBUR H
6,100 +8.2%
16.00
US$97,600 		6,100 +8.2% 16.00 US$97,600
2018-06-26 2018-06-25 B Purchase GANTZ WILBUR H
17,000 +4.8%
16.00
US$272,000 		17,000 +4.8% 16.00 US$272,000
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
52,471 +4.9%
16.00
US$839,536 		52,471 +4.9% 16.00 US$839,536
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
15,741 +4.9%
16.00
US$251,856 		15,741 +4.9% 16.00 US$251,856
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
18,068 +4.9%
16.00
US$289,088 		18,068 +4.9% 16.00 US$289,088
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
23,538 +4.4%
16.00
US$376,608 		23,538 +4.4% 16.00 US$376,608
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
17,305 +4.4%
16.00
US$276,880 		17,305 +4.4% 16.00 US$276,880
2018-06-26 2018-06-25 B Purchase ADAMS STREET PARTNERS LLC Large shareholder
22,877 +4.4%
16.00
US$366,032 		22,877 +4.4% 16.00 US$366,032
Explore more

More insider trading research around Aptinyx Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America